Cellcept and Encephalitis herpes - a phase IV clinical study of FDA data

Summary:

Encephalitis herpes is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Encephalitis herpes when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Encephalitis herpes?

Encephalitis herpes (inflammation of the brain due to herpes infection) is found to be associated with 119 drugs and 261 conditions by eHealthMe. Check the latest studies of Encephalitis herpes.

On Jul, 27, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 11 people (0.03%) have Encephalitis herpes.

Could Cellcept cause Encephalitis herpes?

Among these 11 people:

How long have people been on Cellcept when they have Encephalitis herpes? *

What is the gender of people who have Encephalitis herpes when taking Cellcept? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Encephalitis herpes when taking Cellcept? *

What are other drugs people take besides Cellcept? *

Methotrexate: 7 people, 63.64%
Remicade: 6 people, 54.55%
Dexamethasone: 6 people, 54.55%
Cyclosporine: 6 people, 54.55%
Prograf: 5 people, 45.45%
Acyclovir: 3 people, 27.27%
Sulfamethoxazole And Trimethoprim: 1 person, 9.09%
Solu-Medrol: 1 person, 9.09%
Rocephin: 1 person, 9.09%
Rituxan: 1 person, 9.09%

What are other side effects people have besides Encephalitis herpes? *

Speech Disorder: 4 people, 36.36%
Blood Alkaline Phosphatase Increased: 3 people, 27.27%
Platelet Count Increased: 3 people, 27.27%
Gamma-Glutamyltransferase Increased: 3 people, 27.27%
Blood Lactate Dehydrogenase Increased: 3 people, 27.27%
Aspartate Aminotransferase Increased: 2 people, 18.18%
Drowsiness: 2 people, 18.18%
Communication Disorder (speech and language disorder): 2 people, 18.18%
Fever: 2 people, 18.18%
White Blood Cell Count Increased: 2 people, 18.18%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 54.55%
Immunodeficiency Disorders: 2 people, 18.18%
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Encephalitis herpes?

- Check whether Encephalitis herpes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalitis herpes:

Encephalitis herpes (119 drugs)

Browse all the conditions that are associated with Encephalitis herpes:

Encephalitis herpes (261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.